Inner Banner

International 2026

breadCrumb

Submitted by admin on Wed, 11/19/2025 - 21:12
Type
common
  1. Agate S, Patil S, Sarade M, Lokhande D, Bhojane S, Angane S, Das D, Banavali S, Chaturvedi P, Budukh A (2026). Overall survival of oral cancer from the population-based cancer registries of the Konkan area, Maharashtra, India. BMC Cancer.

  2. Bentzen S, Gupta T, Jacinto A, Rosenblatt E, Bhasker S, Napoles M, Binia S, Chansilpa Y, Aguiar S, Nagarajan M, Ghosh Laskar S, Marchi P, Goloubeva O, Hopkins K, Zubizarreta E, Agarwal J, Abdel-Wahab M (2026). Hypofractionated versus normofractionated accelerated radiation therapy with or without cisplatin for locally advanced head and neck squamous cell carcinoma (HYPNO): A randomized, open-label, Phase 3, noninferiority trial. International Journal of Radiation Oncology,Biology,Physic

  3. Beadle BM, Benzerdjeb N, Cho J, Costes-Martineau V, Faquin WC, Gomez RS, Gupta R, Kholová I, Nagao T, Rane SU, Rito M, Thompson LDR, Samra S, Luk PP, Chiosea SI (2026). International consensus guidelines for diagnostic criteria and checklist for future studies for minimally invasive carcinoma ex pleomorphic adenoma: An HN CLEAR initiative. Head Neck Pathology. 20(1):33

  4. Bancroft E, Page E, McHugh J.......Greenhalgh L, Murthy V...etal. (on behalf of the IMPACT Study Collaborators ) , Brook M, Kate-Zarai Z, Eles R (2026). Targeted prostate cancer screening in carriers of BRCA1 or BRCA2 pathogenic germline variants detects clinically relevant disease: 5-year results from the IMPACT study. European Urology.

  5. Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of Post-Pancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insights from a Comprehensive Cohort Study of 1594 Patients and Development of Predictive Nomograms. Journal of the American College of Surgeons.

  6. Chavda R, Rane SU, Mittal N, Gawde J, Rai D, Mahajan K, Sharma M, Pimple S, Mahimkar MB( 2026). Integrated clinical, histopathological, and inflammatory parameters for predicting malignant transformation in high-risk oral potentially malignant disorders: A prospective study. Head Neck Pathology. 20(1):32

  7. Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P... Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M...etal..., Jabado N, Erker C (2026). Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study. Clinical Cancer Research.

  8. Charnalia M, Ranjan N, Spampinato S, Nout R, Pötter R, Leeuw A, Kirchheiner K, Tanderup K, Chopra S (2026). Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life, Radiotherapy and Oncology.

  9. Chilukuri S, Sundar SC, Subramani V, Arjunan M, Raveendran V, Kamath R, Meena L, Guruvaiah A, Phurailatpam R, Selvaraj R, Chaudhari L, Kumaar V, Jain N, Tiwari M, Halsana P, Sharma D, Maitre P, Murthy V (2026). Pre-PROTO-PRIME study: Stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer — feasibility, acute toxicity and dosimetric insights. Clinical and Translational Radiation Oncology.56:101084.

  10. Das D ,Tandale S, Budukh A(2026) PopMortGen-India: An excel based tool for preparing population mortality files from life tables for relative survival analysis for cancer patients from India. ecancer. 20:2082

  11. Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A (2026). International Radiosurgery Oncology Consortium of the Kidney (IROCK) contouring guidelines for renal cell carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics.

  12. Gohil D, Gandhi KA, Gupta SK, Gera P, Yadav S, Patwardhan R, Checker R, Sharma D, Khattry N, Sandur S, Gota V( 2026). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British Journal of Pharmacology. 183(1):131-152.PMID: 38584000

  13. Gupta R, Fielder T, Bal M..........Chernock R...Kamboj M...Patil A...Rane S...etal. on the behalf of the HN-CLEAR steering committee and clinical advisory group (2026). International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative. Lancet Oncology. 27(1):e33-e44.

  14. Guha A, Gawde J, Mahajan K, Bagal B, Parab A, Rajeshwari A, Shetty N, Kulkarni S (2026). Is looking at the tip of the iceberg sinking our ship? A longitudinal cohort study on the patterns of evolution on treatment of non-enhancing FLAIR lesions in primary CNS lymphoma. Journal of Neurooncology. 177(1):7

  15. Gupta S, Nair N, Hawaldar RW, Joshi S, Gulia S, Shet T, Sarin R, Parmar V, Desai S, Ghosh J, Wadasadawala T, Vanmali V, Panhale T, Parab P, Patil A, Chitkara G, Rath S, Bajpai J, Pathak R, Popat P, Thakur M, Badwe RA (2026). Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 44(1):9-19. PMID: 41115255

  16. Kumar A, Gurav M, Sarkar J, Bapat P, Madhu K, Shetty O, Chatterjee A, Sahay A, Dasgupta A, Moiyadi A, Shetty P, Gupta T, Goda JS, Epari S (2026). Impact of IDH mutation and MGMT methylation as Independent prognostic markers in uniformly treated high grade glioma Patients: A Real-World evidence in the Indian Population. Brain Research. 1877-1878:150205.

  17. Krishnamurthy Manjunath N, Patil V, Shirsat A, Wairagade S, Pradosh A, Kumar S, Jadhav S, Chavan A, Patil A, Joshi A, Prabhash K, Gota V, Noronha V (2026). A prospective, open-label, randomized, crossover study to compare the pharmacokinetics of crushed methotrexate with that of the tablet formulation in patients with head-and-neck cancer. Cancer Research, Statistics and Treatment 9(1):1-7.

  18. Kumari A, Mal A, Thorat R, Saha P, Patel P, Valvi S, CM Krishna, De A, Bandyopadhyaya R (2026). Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer. Biomaterials Advances. 179: 214489. PMID: 40976113

  19. Kizhakethil RV, Varma AK, Bhogale OV, Joshi MA, Barage SH, Kumar AWS, Kamble SS (2026). Conformational dynamics and energetic perturbations in human β-spectrin-II mediated by calpain cleavage-related mutations: Insights from enhanced sampling simulations. Computational Biology and Chemistry.120(Pt 2):108759.PMID: 41192394.

  20. Kannan N, Achrekar A, Terse V, Gawde V, Joshi S, Bhanshe P, Chaudhary S, Salunke P, Ghogale S, Deshpande N, Shetty D, Shetty A, Mirgh S, Nayak L, Gokarn A, Punatar S, Jain H, Bagal B, Sengar M, Khattry N, Rajpal S, Chatterjee G, Tembhare P, Subramanian PG, Patkar N (2026). Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality? Journal of Clinical Pathology.

  21. Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the novel HLA-C*12:03:01:80 allele in an individual from Bihar. HLA. 107(3):e70656

  22. Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the Novel HLA-B Allele, HLA-B*57:198, in an Individual From North India. HLA. 107(1):e70538

  23. Iengar P, Venkatraman P (2026). Using the reactome graph database to generate pathway fingerprints for cancer-related genes, and using the fingerprints to gain insights into cancer, comorbidity, and cancer gene networks. Computational Biology and Chemistry. 120 Part 1: 108686.PMID: 41252800

  24. Inchanalkar M, Chavda R, Gawde J, Patil A, Kaushal RK, Mahimkar MB (2026). Upregulation of Derlin 3 (DERL3) protein expression is associated with Oral Cancer progression and is independent of promoter hypermethylation. BMC Cancer.

  25. Joshi P, Bhawalkar A, Singhavi H, Patil A, Thiagarajan S, Singh A, Shetty R, Gontu GSSR, Nair S, Chaturvedi P (2026). Utility of biopsy and frozen section in detecting malignancy within clinically suspicious verrucous growths: A retrospective study. International Journal of Oral and Maxillofacial Surgery.

  26. Mathen C, Dsouza W, Sharma D, Pradhan TN, Kesarwani A, Gujar D, Choudhary ML, Nithyanand A, Ghosalkar R, Ingle A, Chaudhari P, Goda JS, Kode J (2026). Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management. Scientific Reports.

  27. Malhotra R, Moitra P, Chatterjee A, Kota PK, Dasgupta A, Epari S, Menon N, Kowtal P, Sarin R, Gupta T (2026). Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study. Journal of Neurooncology. 177(1):9.

  28. Mittal P, J. Kamalnath, Charnalia M, Anjana AK, Jain J, Gupta A, Chopra S (2026). Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes. Brachytherapy.

  29. Moirangthem R, Manjrekar A, Pullat GB, Golapkar SV, Margale RS, Sagare S, Talukdar D, Chakraborty N, Pathak R, Pradhan S, Krishnatreya M, Panse N, Dikshit R, Soerjomataram I, Gupta S, Mhatre S (2026). Association of chewing tobacco and the risk of breast cancer in Indian women: A multicentre case-control study. International Journal of Breast Cancer.

  30. Mirgh S, Sood K, Punatar S, Gokarn A, Chichra A, Nayak L, Bain G, Bagal B, Khattry N (2025). MRD-directed consolidation in multiple myeloma – Are we there yet? Clinical Lymphoma Myeloma and Leukemia.

  31. Maitre P, Murthy V (2026). From constraints to confidence: A roadmap of 'Simple' SBRT for low-resource clinical environments. International Journal of Radiation Oncology,Biology,Physics. 124(5): 1175-1177.

  32. Meher R, Maharana J, Kavvuri J, K Nirmal Kumar, Pradhan T, Kailaje V, Ingle A, Sen S, Barkume M, Patkar M, Vaibhaw A, Mir SA, Ghosh A, Kamte S, Kamal A, Kode J (2026). A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies. Bioorganic Chemistry.170:109429.

  33. Naik K, Deshpande G, Bhandare M, Bhargava P, Rekhi B, Ramadwar M (2026). Gastric Synovial sarcoma: A case report and review of literature. International Journal of Surgical Pathology.

  34. Nair S, Shetty R, Bhawalkar A, Joshi P, Singh A, Singhavi H, Sharma JK, Sinha S, Kumar A, Laskar SG, Joshi A, Chaturvedi P (2026). Impact of infratemporal fossa clearance on survival in advanced buccal mucosa cancers. Head Neck.

  35. Nagare M, Sahoo M, Sengar M, Punatar S, Khattry N, Gokarn A, Bagal B, Jain H, Mirgh S, Epari S, Shet T, Pradhan T, Shirsat S, Barkume M, Mathen C, Gera P, Verma RK, Saldanha E, Chandrani P, Gawde J, Chiplunkar S, Kode J (2026). Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent. Cancer Immunology Immunotherapy. 75(3):83.

  36. Ostwal V, Parulekar M, Naughane D, Ramaswamy A, Garkal T, John G, Mandavkar S, Bhargava P, Gupta A, Kapoor A, Joshi P, Shetty O, Srinivas S, Kannan S, Chaugule D, Jadhav P, Joshi A, Ghosh J, Noronha V, Menon N, Prabhash K, Khandare M, More S, Gaud S, Banavali S, Gupta S (2026). Carica papaya leaf extract to improve chemotherapy-induced thrombocytopenia: A phase III triple-blinded, randomized, placebo-controlled, multicentric trial. JCO Global Oncology.(3):e2500386.

  37. Patwardhan R, Rizvi Z, Gota V, Checker R, Singh B, Maurya D, Pal D, Ramani N, Kumar BK, Purohit V, Mathapati BS, Mullick J, Ghanty T, Gupta S, Joshi M, Madki S, Awasthi A, Sandur S, Sharma D (2026). First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent. Phytomedicine. 150: 157689. PMID: 41453293

  38. Pradhan P, Chaudhary T, Mishra S, Konik P, Durinova E, Tuma R, De A, Sinha D (2026). MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell Death and Disease.

  39. Siddiqui A, Dhandapani H, Rather A, Ingle A, Sharma D, Tayalia P (2026). In situ programming of CAR-macrophages via a polyplex nanomaterial and STING activation for triple-negative breast cancer immunotherapy. Nanoscale.

  40. Sable S, Wadasadawala T, Kannan M, Sarin R, Pathak R, Krishnamurthy R, Gulia S, Joshi S, Popat P, Shet T (2026) Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: A prospective observational study. ecancer. 20:2099.

  41. Sarade M, Das D, Mhamane S, Bhojane S, Patil S, Banavali S, Prakash G, Budukh A (2026) Long-term overall survival of testicular cancer: findings from a rural population-based cancer registry, Ratnagiri district, Maharashtra state, India ecancer 20: 2080

  42. Saha S, Trivedi B, Ojha S, Ambulkar R, Nambiar A, Sarwade K, Kumar A, Kannan S (2026). Towards rational blood utilization: development of a transfusion risk prediction tool for onco-surgical practice. World Journal of Surgical Oncology

  43. Sandbhor P, Goda J, Banerjee R, Dyawanapelly S (2026).Targeted dual-drug delivery for minimal residual glioblastoma using multifunctional thermosensitive liposomal hydrogels. Journal of Drug Delivery Science and Technology.

  44. Sinha S, Ghosh Laskar S, Dhingra S, Kumar A, Mohanty S, Budrukkar A, Swain M, Bishnu PN, Joy I, Ali R, Kannan S, Mummudi N (2026). Avoiding adjuvant Prophylactic Neck irradiation in lateralized oral cavity cancer (APRON). Clinical Oncology. 49: 103980

  45. Subramani V, Chauhan, H, David S, Maitre P, Menon S, Joshi A, Misra A, Arora A, Pal M, Prakash G, Murthy V (2026). Efficacy and safety of adjuvant radiotherapy in primary resected adrenocortical carcinoma – A comparative study. Journal of UroOncology 1(1): 24-30.

  46. Saha P, Varyani R, Hole A, Joshi P, Waghmare MS, Singh A, Chaturvedi P, Govekar R, CM Krishna (2026). Multimodal serum profiling for early detection and risk assessment of oral potentially malignant disorders and oral cancer. Analytical Chemistry.

  47. Shenoy V, Kannan S, Noronha V, Prabhash K, Ostwal V, Bhargava P, Pillai A, Shamseeya K, Shetake A, Dhekale R, Chitre A, Gota V, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Nookala M, Banavali SD, Ramaswamy A (2026). Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers. Journal of Geriatric Oncology. 17(2):102817.

  48. Sahu A, Mehta D, Dasgupta A, Dev I, Puranik A, Bhattacharya K, Sahay A, Sridhar E, Shetty P, Moiyadi A, Menon N, Chatterjee A, Gupta T (2026). Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma. Neuroradiology Journal.

  49. Sundararajan R, Harish M, Cherusserikkaran Anthony M, Christie J, Jaiswal D, Venkatraman P (2025). Within and beyond the boundaries of proteasomal assembly: PSMD9 chaperone as a multifunctional protein. Essays in Biochemistry. 69(5):EBC20253044.

  50. Singh M, Ghosh S, Katdare A, Agrawal A, Choudhury S, Phurailatpam R, Patil D, Anaz M, Rangarajan V, Maitre P, Murthy V (2026). PSA and PSMA kinetics after PSMA-PET & MR guided prostate SBRT with focal boost: Results from the phase II PROBE trial. International Journal of Radiation Oncology, Biology, Physics.

  51. Sen S, Mohanty S, Wadasadawala T, Maiti S (2026). The extent of indebtedness among breast cancer survivors in India: A prospective longitudinal study from a tertiary cancer hospital. Journal of Cancer Policy.

  52. Singh AG, Kole L, Sullivan R, Sinha S, Shetty R, Joshi P, Nair S, Laskar SG, Prabhash K, Chaturvedi P (2026). Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck Cancers. Head Neck.

  53. Sundaravadivelu PK, Raina K, Borthakur A, Mahto P, Shetty D, Dhamne C, Kaveeshwar V, Martin CA, Radhakrishnan S, Rela M, Thummer RP (2026). Derivation and characterization of the iPSC line IITGi001-B from primary human adult dermal fibroblasts. Stem Cell Research.

  54. George A, Nair S, Prabhash K, Thakur S, Gera P, Singh A, Chaturvedi P, Rane S, Pradhan T, Sen S, Barkume M, Shetty D, Chaubal K, Ghosh A, Kamte S, Kode J (2026). Generation and characterization of early stage oral cancer cell line of buccal mucosa of Indian origin. Human Cell. 39: 21.

  55. Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2026).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.132:118444

  56. Yegnaswamy S, Selvaa Kumar C, Aldaais E, Shinde I (2026). Structural resilience of conserved-site mutations in the MERS-CoV membrane protein: insights into stability and conformational dynamics. Journal of Biomolecular Structure and Dynamics.

Category
International
Select Year
2026
order
8
Back to Top